Gevokizumab Completed Phase 2 Trials for Type 1 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00998699Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes
NCT01788033Effects of XOMA 052 on Insulin Production in Type 1 Diabetes